Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy

NCT02171390 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Hypogonadotrophic Hypogonadism

Interventions

DRUG: Testosterone 250mg injection
DRUG: Testosteron 50 mg transdermal gel

Sponsor

Gulhane School of Medicine